| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |